Recent studies of IFIT3 have highlighted its function as oncogene in various human cancers including breast cancer, pancreatic cancer, and liver cancer, and high expression of IFIT3 enhanced chemotherapy resistance of PDAC cells and was independently correlated to shorter patients’ survival [23]. Here, IFIT3 is linked to familial pancreatic carcinoma.